Ditemukan 30879 dokumen yang sesuai dengan query :: Simpan CSV
Pendahuluan. Artritis reumatoid (AR) adalah peradangan kronik autoimun yang terutama melibatkan persendian secara bilateral dan simetris. Walaupun memiliki prevalensi yang rendah namun jika tidak diterapi secara adekuat maka akan menimbulkan masalah persendian yang bersifat permanen, kecacatan dan gangguan fungsi sendi sehingga menimbulkan dampak secara ekonomi dan sosial pada individu yang mengalaminya. Penyakit AR ini tidak dapat disembuhkan namun penyakit ini harus tetap ditatalaksana untuk mencegah progresifitas dari penyakit itu sendiri dan saat ini prediksi kegagalan atau keberhasilan terapi MTX belum pernah dilakukan di Indonesia terutama pengembangan terhadap suatu sistem skoring yang aplikatif, hal ini menjadi landasan untuk melakukan analisis faktor-faktor yang memengaruhi kegagalan pengobatan metotreksat pada pasien AR dalam hal ini dalam skala rumah sakit yang menyesuaikan dengan kondisi di Indonesia dan melakukan pengembangan sistem skoring prediktor terhadap kegagalan monoterapi metotreksat. Metode. Penelitian menggunakan desain studi kohort retrospektif yang menggunakan data rekam medis elektronik (RME) pasien poli reumatologi penyakit dalam RSCM pada kurun waktu Oktober 2020 - September 2023. Dilakukan analisis deskriptif dan bivariat dengan menggunakan analisis chi-square yang dilanjutkan dengan analisis multivariat dengan analisis model Generalized Linear Model (GLM) dengan family Poisson untuk mendapatkan nilai koefisien, RR dengan interval kepercayaan 95% dari variabel independen terhadap kegagalan terapi monoterapi metotreksat yang dilanjutkan proses eliminasi variabel melalui metode backward. Hasil. Penelitian ini mendapatkan jumlah sampel sebanyak 215 subyek setelah melalui seleksi kriteria inklusi dan eksklusi, dan didapatkan hasil bahwa jumlah sendi nyeri ≥ 6 memiliki RR 1,52 (CI 95% 1,09-2,16), obesitas memiliki RR 1,41 (CI 95% 1,04-1,24), faktor peradangan LED memiliki RR 2,21 (CI 95%1,07-4,10) dan derajat aktifitas penyakit yang tinggi dengan RR 1,36 (CI 95% 1,03-1,79) adalah variabel yang memengaruhi kegagalan monoterapi metotreksat. Pada pembentukan skoring didapatkan skoring TOLD memiliki nilai kalibrasi dari Hosmer-Lemeshow goodness of fit sebesar 0,29 dan nilai diskriminasi area under curve (AUC) pada kurva receiver operating characteristics (ROC) sebesar 0,71 (CI 95% 0,65-0,78; p-value 0,03). Kesimpulan. Jumlah sendi nyeri ≥ 6, obesitas, faktor peradangan LED dan derajat aktifitas penyakit yang tinggi adalah variabel yang memengaruhi kegagalan monoterapi metotreksat dan pembentukan skoring prediksi TOLD memiliki nilai diskriminasi dan kalibrasi yang cukup baik
Introduction. Rheumatoid arthritis (RA) is a chronic autoimmune inflammation that mainly involves the joints bilaterally and symmetrically. Even though it has a low prevalence, if it is not treated adequately, it will cause permanent joint problems, disability and impaired joint function, causing economic and social impacts on the individuals who experience it. RA disease cannot be cured but this disease must still be managed to prevent progression of the disease itself and currently predictions of failure or success of MTX therapy have never been carried out in Indonesia, especially the development of an applicable scoring system, this is the basis for conducting analysis of factors that influence methotrexate treatment failure in RA patients, in this case on a hospital scale that adapts to conditions in Indonesia and develops a predictor scoring system for failure of methotrexate monotherapy. Methods. The study used a retrospective cohort study design using electronic medical record (RME) data from patients in the RSCM internal medicine rheumatology clinic in the period October 2020 - September 2023. Descriptive and bivariate analysis was carried out using chi-square analysis followed by multivariate analysis using Generalized model analysis. Linear Model (GLM) with the Poisson family to obtain coefficient values, RR with a 95% confidence interval of the independent variable for failure of methotrexate monotherapy therapy, followed by a variable elimination process using the backward method. Results. This study obtained a sample size of 215 subjects after going through selection criteria for inclusion and exclusion, and the results showed that the number of painful joints ≥ 6 had an RR of 1.52 (CI 95% 1.09-2.16), obesity had an RR of 1.41 (CI 95% 1.04-1.24), inflammatory factor ESR had RR 2.21 (CI 95% 1.07-4.10) and high degree of disease activity with RR 1.36 (CI 95% 1.03 -1.79) are variables that influences the failure of methotrexate monotherapy. In forming the scoring, it was found that TOLD scoring had a calibration value from the Hosmer-Lemeshow goodness of fit of 0.29 and an area under curve (AUC) discrimination value on the receiver operating characteristics (ROC) curve of 0.71 (CI 95% 0.65-0 .78; p-value 0.03). Conclusion. The number of painful joints ≥ 6, obesity, ESR inflammatory factors and a high degree of disease activity are variables that influence the failure of methotrexate monotherapy and the formation of TOLD prediction scoring has quite good discrimination and calibration values.
Rheumatoid arthritis (RA)) is a systemic and chronic autoimmune disease which main manifestations involve the joints. AR management requires pharmacological and non-pharmacological therapy. One of the pharmacological RA treatments is methotrexate (MTX). There are many factors that influence the success of RA treatment but in Indonesia there has not been found a study that examines obesity on the success of MTX treatment in RA patients in Indonesia. Researchers wanted to know the effect of obesity on MTX monotherapy failure in patients with AR Methods. A retrospective cohort study using medical records from the Rheumatology Internal Medicine Polyclinic, Cipto Mangunkusumo Hospital (RSCM) from March 2017 to December 2021. A descriptive and estimation analysis was performed to see the sample characteristics based on each variable and a modified Cox regression analysis to see the relationship between obesity and MTX treatment failure. Results. Of the 72 subjects, the proportion of MTX treatment failure in obese patients was 57.1% (20/35), while in patients who were not obese it was 37.8% (14/37). The risk of MTX treatment failure in obese subjects was 1.45 times that of non-obese patients (RR 1.45; 95% CI 0.76-2.78). Number of joints involved, RF factor (RF), C-reactive protein factor (CRP), age, erythrocyte sedimentation rate (ESR), gender, and early onset of disease were not become confounding factors in this study. Conclusion. In this study, RA patients with obesity have an increased risk of MTX treatment failure compared to RA patients without obesity, but further studies using larger samples are needed to increase statistical power.
ABSTRAK Nama : Megawati Program Studi : Epidemiologi Judul : Kesintasan Pasien Kanker Payudara Berdasarkan Keterlambatan Pengobatan di Rumah Sakit Umum Cipto Mangunkusumo Pembimbing : Prof. Dr. dr. Bambang Sutrisna, MHSc (Epidemiology) Abstrak Kanker payudara masih mendominasi penyakit kanker pada wanita di dunia termasuk di Indonesia. Rumah Sakit Cipto Mangunkusumo sebagai rumah sakit rujukan nasional dengan jumlah kasus terus meningkat setiap tahunnya. Sebagian besar kasus ditemukan pada stadium lanjut dan mengalami keterlambatan pengobatan lebih dari 60 hari setelah didiagnosis. Keterlambatan pengobatan diduga berpengaruh terhadap kesintasan pasien kanker payudara. Oleh karena itu penelitian ini dilakukan untuk menilai hubungan keterlambatan pengobatan dengan kesintasan pasien kanker payudara di RSCM. Desain studi penelitian adalah kohort retrospektif dengan mengamati 584 pasien yang memenuhi kriteria inklusi. Pengamatan dilakukan mulai dari 1 Januari 2011 sampai Desember 2017. Data dianalisis secara univariat, bivariat dengan uji logrank, dan multivariat dengan cox regresi. Hasil penelitian menunjukkan dari 584 pasien yang dianalisis ditemukan besarnya risiko terjadinya kematian sebesar 1,27 kali lebih cepat pada pasien yang mengalami keterlambatan pengobatan lebih dari 60 hari dibandingkan dengan pasien yang mendapatkan pengobatan kurang dari 60 hari (HR=1,27; 95%CI;0,99 – 1,64) setelah dikontrol stadium klinis, status pernikahan, dan status hormon reseptor estrogen. Perbedaan kesintasan antara pasien yang terlambat lebih dari 60 hari setelah didiagnosis adalah sebesar 7% pada tahun kelima. Berdasarkan penelitian ini dapat disimpulkan bahwa keterlambatan pengobatan lebih dari 60 hari setelah didiagnosis mempengaruhi kesintasan pasien kanker payudara sehingga pentingnya edukasi kepada pasien dan keluarga untuk tidak menunda pengobatan setelah didiagnosis. Kata kunci: keterlambatan pengobatan; kesintasan; kanker payudara
ABSTRACT Name : Megawati Study Program : Epidemiologi Title : Survival of Breast Cancer based on Delay treatment at Cipto Mangunkusumo Hospital Counsellor : Prof. Dr. dr. Bambang Sutrisna, MHSc (Epidemiology) Breast cancer still dominates cancer in women in the world including in Indonesia. Cipto Mangunkusumo Hospital as a national referral hospital with the number of cases continues to increase every year. Most of the cases were found at an advanced stage and experienced treatment delays more than 60 days after diagnosis. Treatment delays are thought to affect the survival of breast cancer patients. Therefore, this study was conducted to assess the relationship of delayed treatment with survival of breast cancer patients at RSCM. The study design was a retrospective cohort by observing 584 patients who met the inclusion criteria. Observations were done from 1 January 2011 to December 2017. Data were analyzed univariat, bivariate with logrank test, and multivariate with cox regression. The results of the study showed that the 584 patients analyzed found that the risk of death was 1.27 times faster in patients who experienced treatment delay more than 60 days compared with patients who received treatment less than 60 days (HR = 1.27; 95% CI; 0,99 - 1.92) after controlled marital status, hormone receptor estrogen, and clinical stage. The difference in survival between their patients who were late more than 60 days after the diagnosis was 7% in the fifth year. Based on this research, it can be concluded that the delay of treatment influences survival of breast cancer patients so that the importance of education to the patient and family to immediately perform treatment after diagnosis. Keywords : Delay treatment; Survival; Breast Cancer
HIV/AIDS impact to increased susceptibility to other diseases infections whichlead to death. The death of AIDS is also a problem, especially in Indonesia.According to UNAIDS, Indonesia is included in the list of countries where deathsfrom AIDS do not decline or rate of less than 25% of his descent. This research isobservational research, design with cross sectional. This research aims to know thedescription and the main factors which related to mortality of AIDS HIV/AIDS ininpatient unit RSUPN Dr Cipto Mangunkusumo in 2008-2012. The sample of thisresearch are 207 patients. Data collected by utilizing the patient's medical record datato see the independent variables consisted of gender, age, job, CD4 levels, risk factorsof transmission, the amount of illness suffered, nutritional status, history of centralnervous disorders, drug consumption history ARV consumption, and psychologicalconditions to be linked with the status of a patient's death related with HIV/AIDS.The data analysis done to multivariate analysis with prediction model. The resultsshowed that the AIDS death prevalence reach up to 28.5%. The results ofMultivariate analysis obtained 4 variables related to the death of AIDS, poornutritional status (OR=4,75) with 95% CI (2,278-9,917), central nervous disorderhistory (OR=1,82) with 95% CI (1,025-3,251), the number of illnesses suffered morethan 5 disease (OR=4,09) with 95% CI (1,854-9,043), and CD4 levels. CD4 levelsbecame the most influential factors towards AIDS deaths with a value of 5, 9 OR and95% CI (2,096-17,106). From the results can be recommended the efforts toincreased awareness toward control CD4 blood levels for HIV/AIDS patients andother supporting efforts to prevent deaths of AIDS such as improved quality ofnutrition AIDS patients, screening and early detection of central nervous disorders,and prevention of complications of the disease.Keywords: HIV/AIDS, Death, CD4 level, main determinant
Background: The patients prevalence who experience worsening clinical conditions on the general ward is 15-20%, which causes a serious outcome, namely death. Mortality events in this group of patients who were called rapid response team were influenced by high NEWS score points. Objective: To determine the association between NEWS and mortality in patients who have called TMRC at Dr. Cipto Mangunkusumo Hospital. Methods: This study used a retrospective cohort design from the medical records of patients who have called TMRC in all hospital areas except the operating room, intensive care, and emergency department. The sample was selected using total sampling, analyzed using Kaplan-meier survival analysis and cox extended model analysis. Results: Patients who have called TMRC with a high NEWS score in less than 15 days had increased risk of mortality aHR 2,86, 95% CI 2,18?3,77, p-value 0,000 in those who did not have chronic liver disease. Meanwhile, in patients with a high NEWS score who had chronic liver disease the risk of mortality increased to aHR 4,17, 95% CI 1,39?12,44, p-value 0,01 after being controlled with sepsis. Conclusion: A high NEWS score at less than 15 days had almost 3-fold increased risk of mortality in those without chronic liver disease. Meanwhile, in patients who have chronic liver disease, the risk of mortality increases to 4 times after being controlled with sepsis.
Introduction, Glaucoma is the second largest cause of blindness in Indonesia. Blindness caused by glaucoma is irreversible and most of the patients are unaware of the symptoms. The proportion of blindness in new glaucoma patients at RSUPN Dr Cipto Mangunkusumo (RSCM) in that period was high, so that, the factors related to the blindness need to be explored.
Based on the WHO report 2013, extra-pulmonary TB cases in Indonesia have increased from 14.054 in 2012 to 15.697 in 2013. One of hospitals which get an increase of extra-pulmonary TB cases is National Center General Hospital Dr. Cipto Mangunkusumo Jakarta, so, this study ultimately aims to identify risk factors that associated with extra-pulmonary TB to TB hospitalized patients in National Center General Hospital Dr. Cipto Mangunkusumo Jakarta 2011-2013.
